Literature DB >> 22770911

The EUTOS score identifies chronic myeloid leukeamia patients with poor prognosis treated with imatinib first or second line.

Massimo Breccia, Paola Finsinger, Giuseppina Loglisci, Roberto Latagliata, Marco Mancini, Adriano Salaroli, Alessandra Serrao, Irene Zacheo, Giuliana Alimena.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22770911     DOI： 10.1016/j.leukres.2012.05.011

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  7 in total

1.  Prognostic discrimination for early chronic phase chronic myeloid leukemia in imatinib era: comparison of Sokal, Euro, and EUTOS scores in Korean population.

Authors:  Seung-Ah Yahng; Eun-Jung Jang; Soo-Young Choi; Sung-Eun Lee; Soo-Hyun Kim; Dong-Wook Kim
Journal:  Int J Hematol       Date:  2014-05-31       Impact factor: 2.490

2.  European Treatment and Outcome Study score does not predict imatinib treatment response and outcome in chronic myeloid leukemia patients.

Authors:  Eri Yamamoto; Shin Fujisawa; Maki Hagihara; Masatsugu Tanaka; Katsumichi Fujimaki; Kumiko Kishimoto; Chizuko Hashimoto; Megumi Itabashi; Daisuke Ishibashi; Yuki Nakajima; Takayoshi Tachibana; Rika Kawasaki; Hideyuki Kuwabara; Hideyuki Koharazawa; Etsuko Yamazaki; Naoto Tomita; Rika Sakai; Hiroyuki Fujita; Heiwa Kanamori; Yoshiaki Ishigatsubo
Journal:  Cancer Sci       Date:  2014-01-23       Impact factor: 6.716

3.  Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era-experience from a tertiary oncology centre in Southern India.

Authors:  Lakshmaiah Chinnagiriyappa Kuntegowdanahalli; Govind Babu Kanakasetty; Aditi Harsh Thanky; Lokanatha Dasappa; Linu Abraham Jacob; Suresh Babu Mallekavu; Rajeev Krishnappa Lakkavalli; Lokesh N Kadabur; Rudresha Antapura Haleshappa
Journal:  Ecancermedicalscience       Date:  2016-10-06

4.  The Hasford Score May Predict Molecular Response in Chronic Myeloid Leukemia Patients: A Single Institution Experience.

Authors:  Jarosław Dybko; Bożena Jaźwiec; Olga Haus; Donata Urbaniak-Kujda; Katarzyna Kapelko-Słowik; Tomasz Wróbel; Tomasz Lonc; Mateusz Sawicki; Ewa Mędraś; Agnieszka Kaczmar-Dybko; Kazimierz Kuliczkowski
Journal:  Dis Markers       Date:  2016-10-12       Impact factor: 3.434

5.  Consistency Test between Scoring Systems for Predicting Outcomes of Chronic Myeloid Leukemia in a Saudi Population Treated with Imatinib.

Authors:  Haneen R Banjar; Enaam Alsobhi
Journal:  Int Sch Res Notices       Date:  2017-02-13

6.  Aplasia in Chronic Phase CML Post-TKI Therapy: A Management Dilemma.

Authors:  Jeremy L Ramdial; Luis E Aguirre; Robert A Ali; Ronan Swords; Mark Goodman
Journal:  Case Rep Hematol       Date:  2019-09-22

7.  Effectiveness of Three Prognostic Scoring Systems in Predicting the Response and Outcome in Pediatric Chronic Myeloid Leukemia Chronic Phase on Frontline Imatinib.

Authors:  Ranga Raman Ganta; Srividya Nasaka; Vijay Gandhi Linga; Sadashivudu Gundeti; Lakshmi Srinivas Maddali; Raghunadha Rao Digumarti
Journal:  Indian J Med Paediatr Oncol       Date:  2017 Jul-Sep
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.